At diagnosis, HERC1 transcript levels are markedly down-regulated in AML, CML and primary myelofibrosis, an aggressive form of myeloproliferative neoplasm (MPN), relatively to bone marrow and peripheral blood control cells. This evidence concerns the gene HERC1 and myeloproliferative disorder.